FDA.reportPublic FDA data

Treanda 180 MG per 2 ML Injection

RxCUI
1805012
RxNorm name
Treanda 180 MG per 2 ML Injection
Display name
Treanda 180 MG per 2 ML Injection
Full name
Treanda 180 MG per 2 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TREANDABENDAMUSTINE HYDROCHLORIDECephalon, LLC39d53698-57fa-7c99-fc5b-f52a556848262022-10-27Warnings, Adverse reactionsExact identifier
rxcui: 1805012

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
39d53698-57fa-7c99-fc5b-f52a55684826Treanda 180 MG in 2 ML Injection [PSN] · 2 ML bendamustine hydrochloride 90 MG/ML Injection [Treanda] [SBD] · Treanda 180 MG per 2 ML Injection [SY]326These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 200820221027